Meticulous Research®, a premier global market research firm, has released its comprehensive report on the High Throughput Screening (HTS) market, forecasting a robust growth trajectory. The market is projected to attain a valuation of $47.41 billion by 2031, expanding at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3206
The burgeoning HTS market is driven by several pivotal factors, including the escalating adoption of cutting-edge methodologies within pharmaceutical and biotechnology sectors, heightened funding for drug discovery, an increasing array of drug targets for screening, and a growing number of HTS facilities. Nevertheless, market growth is tempered by substantial capital investment requirements and evolving government regulations pertaining to drug development.
Market Insights and Opportunities
Key growth opportunities are anticipated in regions such as Singapore and India, owing to the expansion of their biotechnology sectors. Furthermore, technological advancements in HTS—including multiplexed assays, assay miniaturization, AI integration, Ultra-High-Throughput Screening (uHTS), and organ-on-chip innovations—are expected to catalyze market development. However, challenges such as complex HTS data handling and potential false positive results may impact growth.
Market Segmentation and Trends
The report delineates the HTS market across various segments:
• Technologies: Cell-Based Assays (2D and 3D Cell Cultures), Label-free, Lab-on-Chip, and more.
• Offerings: Consumables & Reagents, Instruments (Sample Preparation, Liquid Handling, Readers), Software & Services.
• Applications: Stem Cell Research, Toxicology Assessment, Target Identification, Primary Screening.
• End Users: Pharmaceuticals and Biotechnology Industry, Academic and Research Institutes, Contract Research Organizations.
In 2024, the Consumables & Reagents segment is anticipated to hold the largest market share due to advancements in kit development and the widespread availability of HTS consumables. The Cell-Based Assays segment, particularly 3D Cell Culture, is projected to experience the highest CAGR, attributed to its ability to simulate organ microarchitecture and provide more accurate disease modeling.
Regional Analysis
Geographically, the Asia-Pacific region is poised for the highest CAGR during the forecast period, with China leading this growth. The surge in pharmaceutical R&D spending and an increase in drug discovery activities in China significantly bolster the HTS market. Notably, in the first quarter of 2022, China saw a record number of investigational new drug (IND) and new drug application (NDA) approvals.
Key Players
Prominent players in the global HTS market include:
• Thermo Fisher Scientific, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Merck KGaA (Germany)
• Danaher Corporation (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Revvity Inc. (U.S.)
• Tecan Group Ltd. (Switzerland)
• Axxam S.p.A. (Italy)
• Charles River Laboratories International, Inc. (U.S.)
• Hamilton Company (U.S.)
• Promega Corporation (U.S.)
• Aurora Biomed Inc. (Canada)
Quick Buy @ https://www.meticulousresearch.com/Checkout/82641893
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research